Solara Active Pharma Science Receives Zero Observations for Chennai Unit

Solara Active Pharma Science has received zero observations from the US health regulator for Chennai unit. “Solara announced the successful completion of US FDA inspection at Solara Research Center (SRC), Chennai with zero 483s inspectional observations,” the company said in its filing. Established in 2005, SRC is a state-of-the-art R&D center with capabilities to develop niche products characterized by complex chemistry across the diverse therapeutic categories. SRC was earlier inspected by USFDA as control testing laboratory in December 2012 and August 2016. – Money Control